English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/59466
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances

AuthorsCamacho, Emma; Hernández, Luis; Hernández, Silvia; Tort, Frederic; Bellosillo, Beatriz; Beà, Silvia; Bosch, Francesc; Montserrat, Emili; Cardesa, Antonio; Fernández, Pedro L.; Campo, Elías
Issue Date2002
PublisherAmerican Society of Hematology
CitationBlood 99(1): 238-244 (2002)
AbstractThe ataxia-telangiectasia mutated (ATM) gene codifies for a protein critically involved in the cellular response to DNA damage, ATM alterations have been observed in some sporadic lymphoproliferative disorders. The recurrent 11q22-23 deletions found in mantle cell lymphoma (MCL) suggest that ATM could be inactivated in these lymphomas. In this study, ATM gene alterations and protein expression were examined in 20 and 17 MCL tumor specimens, respectively. Previously, these patients had been examined for p53 and p14ARF gene status and analyzed by comparative genomic hybridization. Nine patients had 11q22-23 losses. Eight ATM gene mutations were detected in 7 patients. These alterations were 3 missense mutations in the phosphatidyl-inositol-3 kinase (PI-3K) domain and 5 truncating mutations,including 3 frame-shifts, a nonsense mutation, and a substitution of the initial methionine. All truncating mutations were associated with lack of protein expression. Somatic origin was demonstrated in 3 mutations, whereas one mutation was carried heterozygously in the patient germ line. Chromosomal imbalances were significantly higher in typical MCL with ATM inactivation(7.8 ± 1.3) than in tumors with the wild-type gene (3 ± 1.1) (P= .001). Moreover, tumors with bi-allelic ATM alteration were associated with 3q gains (P = .015) and frequent extranodal involvement (P = .049). ATM gene alterations were not related to the histologic variant of the tumors,p53/p14ARF gene status, survival, or other clinicopathologic features of the patients. These findings indicate that ATM gene mutations in MCL are mainly truncating or missense mutations involving the PI-3K domain,and that may play a role in the pathogenesis of a subset of these tumors with increased numbers of chromosomal imbalances. © 2002 by The American Society of Hematology.
URIhttp://hdl.handle.net/10261/59466
DOI10.1182/blood.V99.1.238
Identifiersdoi: 10.1182/blood.V99.1.238
issn: 0006-4971
e-issn: 1528-0020
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.